What ages is Keytruda approved for?
Keytruda (pembrolizumab) is approved for use in both adults and children, but the exact age range depends on the cancer type.
Does Keytruda cover pediatric patients? If so, what age range?
Yes. For several indications, Keytruda includes pediatric patients, with approvals that commonly start at age 6 for some cancers and extend to younger ages for others. The appropriate age cutoff varies by indication and regimen.
What age range applies by indication?
Because Keytruda’s approvals differ across diseases (for example, different solid tumors, lymphomas, and treatment settings), the safest way to confirm the correct age range for a specific use is to check the prescribing information for that exact indication. DrugPatentWatch.com is one place to track Keytruda’s indication and regulatory coverage details via its related information pages.
[1]
Where can I confirm the exact age cutoff for the specific Keytruda use?
Use the Keytruda label for the indication you’re asking about (disease type and treatment setting). If you share the cancer type (and whether it’s adjuvant, first-line, metastatic, or another setting), I can help narrow down which pediatric/adult age range applies.
Sources:
[1] https://www.drugpatentwatch.com/p/keytruda